Riskpilot← Back to searchSign inGet full accessFysiO Med Västerås AB
ABActiveOrg 5565020392Neptungatan 2 Lght 1401Physiotherapy activities · NACE 8695Est. 19941 employees
Revenue 2025
SEK 1,4M
0% vs 2024
EBITDA margin
26.2%
+63% vs 2024
Equity ratio
75.4%
Financial strength
Net profit 2025
SEK 399K
-72% vs 2024
| Revenue | SEK 1,4M | +0% |
| EBITDA | SEK 362K | +63% |
| Net profit | SEK 399K | -72% |
| Total assets | SEK 609K | -61% |
| Equity | SEK 459K | -69% |
| Employees | 1 | — |
Legal name
FysiO Med Västerås AB
Org number
5565020392
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
28 december 1994
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva sjukgymnastik och rehabilitering samt undervisning inom dessa områden samt därmed förenlig verksamhet.
Address
Neptungatan 2 Lght 1401
Phone
+4627810750
Email
ingela@fysiomedics.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 452 | 1 414 | 1 376 | 1 379 |
| Staff expenses | — | −356 | −1 335 | −1 186 | −942 |
| EBITDA | −26 | 75 | 105 | 223 | 362 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −26 | 75 | 105 | 223 | 362 |
| Net financials | 3 500 | 2 102 | 8 | 1 227 | 202 |
| Profit before tax | 3 528 | 2 176 | 112 | 1 450 | 564 |
| Tax | −0 | −16 | −24 | −46 | −165 |
| Net profit | 3 528 | 2 160 | 88 | 1 403 | 399 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 603 | 4 490 | 3 868 | 1 543 | 609 |
| Equity | 3 598 | 3 558 | 147 | 1 460 | 459 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 5 | 932 | 3 722 | 83 | 150 |
| Total debt | 5 | 932 | 3 722 | 83 | 150 |
EBITDA margin
26.2%
This company
15.8%
Market median
+66% vs market
20212025
Equity ratio
75.4%
This company
38.2%
Market median
+97% vs market
20212025
Return on equity
86.9%
This company
18.4%
Market median
+372% vs market
20212025
Net profit margin
28.9%
This company
8.1%
Market median
+257% vs market
20212025
Asset turnover
2.27×
This company
1.12×
Market median
+103% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
GM Audit | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FysiO Med Västerås AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnel Maria Körkkö | Audit | 0 companies |
| Lars-Magnus Keller | Deputy Board Member | 0 companies |
| Tapio Tapani Tengvall | Deputy Board Member | 0 companies |
| Ingela Margareta Lundholm Tengvall | Board of Directors | 0 companies |